Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmeceutical Claims May Be Headed Into FDA's Radar

This article was originally published in The Tan Sheet

Executive Summary

FDA under the Obama administration may cast a sharper eye on cosmeceuticals than the agency has in years past, according to Georgia C. Ravitz, a food and drug law lawyer at Arent Fox

You may also be interested in...



Beauty Claims "Blur" Difference From Drugs As Cosmeceutical Market Grows

Analysts agree cosmeceuticals remain a promising growth vehicle despite the notable regulatory questions the products can create.

Beauty Claims "Blur" Difference From Drugs As Cosmeceutical Market Grows

Analysts agree cosmeceuticals remain a promising growth vehicle despite the notable regulatory questions the products can create.

Beauty Claims "Blur" Difference From Drugs As Cosmeceutical Market Grows

Analysts agree cosmeceuticals remain a promising growth vehicle despite the notable regulatory questions the products can create.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS103205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel